CLSTN1 and Alzheimer disease: They revealed that 6 synaptic proteins including: CLSTN-1, GluR4, NXRN2A, NRXN3A, STX1B and Thy-1, exhibit clinical usefulness in the evaluation of disease progression, particularly in periclinal stages of AD [57].